PORTLAND, Ore., July 29, 2026 /PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced it has received a strategic investment from Axogen, Inc. (NASDAQ: AXGN), the global leader in surgical solutions for...
Hence then, the article about trace biosciences announces strategic investment from axogen to advance clinical development of its nerve trace nerve specific imaging technology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology )
Also on site :
- Monroe County committees vote to accept $160,000 Operation Stonegarden border security grant despite opposition
- ‘Jumanji: Open World’ Trailer: Dwayne Johnson, Kevin Hart and Jack Black Return for Third and Final Movie
- Beloved Romance Author Wants to Turn Jen Hamilton's Divorce Into Her Nex Best Seller — Under One Condition